Symbiotec Pharmalab IPO Subscription
ListedUpdated 1 September 2026, 9:15 AM IST· Mainboard
Symbiotec Pharmalab IPO subscription closed on 27 August 2026 at 75.06x overall by shares. QIB demand came in at 181.20x, NII at 77.56x, and retail at 13.65x. See Retail, SHNI, and BHNI allotment chances in the table…
Symbiotec Pharmalab IPO subscription closed on 27 August 2026 at 75.06x overall by shares. QIB demand came in at 181.20x, NII at 77.56x, and retail at 13.65x. See Retail, SHNI, and BHNI allotment chances in the table below.
Show moreShow less
Allotment date is 28 August 2026. Listing date on NSE and BSE is 1 September 2026.
Symbiotec Pharmalab IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 24 Aug 2026 | 0.37x | 1.10x | 1.01x | 0.85x |
| Day 2 - 25 Aug 2026 | 0.57x | 3.16x | 2.22x | 1.95x |
| Day 3 - 26 Aug 2026 | 0.62x | 12.86x | 5.38x | 5.62x |
| Day 4 - 27 Aug 2026 | 181.20x | 77.56x | 13.69x | 75.08x |
Symbiotec Pharmalab IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
Symbiotec Pharmalab IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
| Category | Subscription (Apps) | Allotment Chances |
|---|---|---|
| Retail | 11.70x | 1 in 12 |
| SHNI (Rs 2L to Rs 10L) | 56.19x | 1 in 56 |
| BHNI (above Rs 10L) | 17.77x | 1 in 18 |
Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.
Check the Symbiotec Pharmalab IPO Allotment Status page from 28 August 2026 for your result.
Symbiotec Pharmalab IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 988.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 350.80 Cr | Rs 63,563.89 Cr | 181.20x |
| FII | - | Rs 12,443.59 Cr | - |
| DFI | - | Rs 36,325.71 Cr | - |
| Mutual Funds | - | Rs 3,457.09 Cr | - |
| Other | - | Rs 11,337.50 Cr | - |
| NII | Rs 263.10 Cr | Rs 20,405.67 Cr | 77.56x |
| bNII (above Rs 10L) | Rs 175.40 Cr | Rs 15,318.59 Cr | 87.34x |
| Corporate | - | Rs 123.88 Cr | - |
| Individual | - | Rs 14,456.80 Cr | - |
| Other | - | Rs 737.92 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 87.70 Cr | Rs 5,087.08 Cr | 58.01x |
| Corporate | - | Rs 14.30 Cr | - |
| Individual | - | Rs 4,896.70 Cr | - |
| Other | - | Rs 176.08 Cr | - |
| Retail | Rs 613.90 Cr | Rs 8,379.26 Cr | 13.65x |
| Cut-off price | - | Rs 7,134.16 Cr | - |
| Fixed price | - | Rs 1,245.10 Cr | - |
| Employee | Rs 3.30 Cr | Rs 53.85 Cr | 16.32x |
| Cut-off price | - | Rs 45.02 Cr | - |
| Fixed price | - | Rs 8.84 Cr | - |
| Total | Rs 1,231.10 Cr | Rs 92,402.67 Cr | 75.06x |
Symbiotec Pharmalab IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 35,50,608 | 1,308 | 0.00x |
| FII | - | 124 | - |
| DFI | - | 108 | - |
| Mutual Funds | - | 55 | - |
| Other | - | 1,021 | - |
| NII | 12,681 | 3,87,775 | 30.58x |
| bNII (above Rs 10L) | 8,454 | 1,50,256 | 17.77x |
| Corporate | - | 1,197 | - |
| Individual | - | 1,41,789 | - |
| Other | - | 7,270 | - |
| sNII (Rs 2L to Rs 10L) | 4,227 | 2,37,519 | 56.19x |
| Corporate | - | 594 | - |
| Individual | - | 2,28,671 | - |
| Other | - | 8,254 | - |
| Retail | 4,14,237 | 48,45,141 | 11.70x |
| Cut-off price | - | 41,03,210 | - |
| Fixed price | - | 7,41,931 | - |
| Employee | 2,227 | 23,544 | 10.57x |
| Cut-off price | - | 19,988 | - |
| Fixed price | - | 3,556 | - |
| Total | 39,79,753 | 52,57,768 | 1.32x |
What Do These Subscription Numbers Mean?
75.06x overall by shares means bids covered about 75 times the shares on offer. Allotment chances depend on applications in each category.
QIB at 181.20x by shares shows institutional demand from mutual funds, FIIs, and banks.
NII covers bids above Rs 2 lakh (30.58x by applications). Split: SHNI 56.19x, BHNI 17.77x by applications. SHNI and BHNI allotment is by lottery.
At 11.70x subscription by applications, about 1 in 12 retail applicants may get allotment (~9% chance per application). Retail allotment is also by lottery.
Symbiotec Pharmalab IPO GMP After Subscription
GMP for Symbiotec Pharmalab IPO stands at Rs 185.00 today, giving an estimated listing price of Rs 1,173.00 per share.
The GMP has moved lower from Rs 220.00 on 19 Aug 2026 to Rs 185.00 on 1 Sept 2026.
A subscription of 75.06x combined with a GMP of 18.72% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Symbiotec Pharmalab IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Symbiotec Pharmalab IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 24 August 2026 |
| IPO Close Date | 27 August 2026 |
| Allotment Date | 28 August 2026 |
| Refund Initiation | 29 August 2026 |
| Share Credit to Demat | 29 August 2026 |
| Listing Date | 1 September 2026 |
| Minimum Investment | Rs 14,820.00 |
| Lot Size | 15 shares |
About Symbiotec Pharmalab IPO
Symbiotec Pharmalab Limited (incorporated in 2002) is an established research-driven pharmaceutical and biotechnology company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), particularly corticosteroids and steroidal-hormone APIs, alongside contract development and manufacturing (CDMO) services and complex injectables. The company operates industrial-scale manufacturing facilities at Rau and Pithampur SEZ in Madhya Pradesh with US FDA, EU-GMP, and WHO-GMP approvals, alongside newly commissioned biomanufacturing facilities in Ujjain and dedicated complex injectables facilities in Mhow. As of March 31, 2026, Symbiotec served over 200 customers across more than 40 countries, holding 43 US FDA Drug Master Files (DMFs) and 23 European Certificates of Suitability (CEPs).
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
Retail - Retail Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Symbiotec Pharmalab IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Symbiotec Pharmalab IPO Details
Issue size, price, financials, and company info
Symbiotec Pharmalab IPO GMP
Live grey market premium and listing estimate
Symbiotec Pharmalab IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Symbiotec Pharmalab IPO Allotment
Allotment date, chances, and check by PAN
Symbiotec Pharmalab IPO Review
SWOT, strengths, risks, and IPO review
Symbiotec Pharmalab IPO FAQ
Common questions on dates, GMP, and allotment
Symbiotec Pharmalab IPO Registrar
Registrar website and how to check allotment
Symbiotec Pharmalab IPO Timeline
Open, close, allotment, and listing dates
Symbiotec Pharmalab IPO News
Updates, blogs, and latest IPO news
Symbiotec Pharmalab IPO Subscription FAQs
What is Symbiotec Pharmalab IPO subscription status today?
Symbiotec Pharmalab IPO subscription closed on 27 August 2026 with overall subscription of 75.06x (by shares) as of 9 September 2026, 6:01 PM IST. QIB 181.20x, NII 30.58x, Retail 11.70x.
What is the overall subscription of Symbiotec Pharmalab IPO?
Symbiotec Pharmalab IPO is subscribed 75.06x overall by shares at close on 27 August 2026. QIB 181.20x, NII 30.58x, and Retail 11.70x.
What is Symbiotec Pharmalab IPO QIB subscription?
Symbiotec Pharmalab IPO QIB (Qualified Institutional Buyers) subscription is 181.20x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Symbiotec Pharmalab IPO Retail subscription?
Symbiotec Pharmalab IPO Retail subscription is 11.70x by applications. Retail bids are up to Rs 2 lakh per PAN.
What is Symbiotec Pharmalab IPO NII, SHNI, and BHNI subscription?
Symbiotec Pharmalab IPO NII subscription is 30.58x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 56.19x and BHNI (above Rs 10L) at 17.77x.
What are Symbiotec Pharmalab IPO retail allotment chances?
At 11.70x subscription by applications, about 1 in 12 retail applicants may get allotment (~9% chance per application). Allotment is by lottery. Share subscription was 13.65x. Allotment chances use applications, not share volume.
What are Symbiotec Pharmalab IPO SHNI allotment chances?
At 56.19x subscription by applications, about 1 in 56 SHNI applicants may get allotment (~2% chance per application). Allotment is by lottery. Share subscription was 58.01x. Allotment chances use applications, not share volume.
What are Symbiotec Pharmalab IPO BHNI allotment chances?
At 17.77x subscription by applications, about 1 in 18 BHNI applicants may get allotment (~6% chance per application). Allotment is by lottery. Share subscription was 87.34x. Allotment chances use applications, not share volume.
When is Symbiotec Pharmalab IPO allotment date?
Symbiotec Pharmalab IPO allotment date is 28 August 2026. Check Symbiotec Pharmalab IPO Allotment Status on IPOwiz from that day using your PAN.
When does Symbiotec Pharmalab IPO subscription close?
Symbiotec Pharmalab IPO subscription closed on 27 August 2026. No new applications are accepted after the close.
What is Symbiotec Pharmalab IPO GMP today?
Symbiotec Pharmalab IPO GMP is ₹185 today (+18.72% over issue price ₹988). See live GMP on the Symbiotec Pharmalab IPO GMP Today page.
What is Symbiotec Pharmalab IPO issue price and lot size?
Symbiotec Pharmalab IPO issue price is ₹988 per share. Lot size is 15 shares. Minimum investment is ₹14,820 per lot. Issue size: ₹1,757.00 Cr.
When is Symbiotec Pharmalab IPO listing date?
Symbiotec Pharmalab IPO listing date is 1 September 2026 on NSE and BSE. Allotment is on 28 August 2026.
How does subscription affect Symbiotec Pharmalab IPO allotment?
In Symbiotec Pharmalab IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 75.06x overall, competition is very high.
For allotment results from 28 August 2026, visit the Symbiotec Pharmalab IPO Allotment Status page. For listing day updates on 1 September 2026, download the IPOwiz App.
Sources
We match Symbiotec Pharmalab IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.